DS

Dandu Smitha Devi

Active Director Director DIN 07104718
DIN 07104718 First appointment Feb 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Dandu Smitha Devi

Data last updated:

Dandu Smitha Devi is a Director at Alsynth Remedies Ltd (since 2015). The company operates in Healthcare. Alsynth Remedies Ltd reported revenue of ₹98.4 Lakh (FY 2022).

DIN 07104718
Primary Designation Director
Industry Healthcare
First Appointment 23 Feb 2015
Oldest Company Age 42 yrs
Largest company Alsynth Remedies Ltd · ₹98.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alsynth Remedies Ltd U24231TG1984PLC004955
Director23 Feb 20151984₹98.4 Lakh (FY 2022)Active

Board colleagues of Dandu Smitha Devi

Directorship timeline

Open interactive timeline →
Alsynth Remedies Ltd
Premium access

Shareholding and investment profile for Dandu Smitha Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dandu Smitha Devi

Dandu Smitha Devi currently holds 1 directorship: Alsynth Remedies Ltd (Director, since 23 Feb 2015, revenue ₹98.4 Lakh (FY 2022)).

Dandu Smitha Devi was first appointed on 23 Feb 2015 as Director at Alsynth Remedies Ltd.

The current boards of Dandu Smitha Devi's companies include Dandu Leela Vijaya Lakshmi (Alsynth Remedies Ltd), Dandu Sirish Prashanth (Alsynth Remedies Ltd), Dandu Surya Prasad Raju (Alsynth Remedies Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available